Hepatitis C Treatment Study Suspended

August 02, 2012 at 02:42PM

NEW YORK (AP) — Drugmaker Bristol-Myers Squibb Co. is suspending a midstage study of a potential hepatitis C treatment because of a serious patient safety issue.

Hepatitis C Treatment Study Suspended from U.S. News